FDA — authorised 30 December 2004
- Application: NDA021723
- Marketing authorisation holder: CP PHARMS
- Local brand name: LYRICA
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 placebo and pregabalin in United States
FDA authorised placebo and pregabalin on 30 December 2004
Marketing authorisations
FDA — authorised 30 December 2004
- Application: NDA021446
- Marketing authorisation holder: UPJOHN
- Local brand name: LYRICA
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 10 June 2005
- Application: NDA021724
- Marketing authorisation holder: CP PHARMS
- Local brand name: LYRICA
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 4 January 2010
- Application: NDA022488
- Marketing authorisation holder: UPJOHN
- Local brand name: LYRICA
- Indication: SOLUTION — ORAL
- Status: approved
Frequently asked questions
Is placebo and pregabalin approved in United States?
Yes. FDA authorised it on 30 December 2004; FDA authorised it on 30 December 2004; FDA authorised it on 10 June 2005.
Who is the marketing authorisation holder for placebo and pregabalin in United States?
CP PHARMS holds the US marketing authorisation.